Patients with the rs1799971 AA genotype may have decreased opioid dose requirements as compared to patients with the AG or GG genotypes. However, conflicting evidence has been reported. This drug-variant pair has been assigned a 鈥渘o recommendation鈥?by CPIC, as it was determined to be not clinically actionable. Other genetic or clinical factors may also affect opioid dose requirements.